The Swedish National Board of Health and Welfare, known as Ivo, is set to receive enhanced powers to tackle prescription fraud, which costs taxpayers several hundred million crowns annually. Issues arise when medications, such as those for diabetes, are prescribed not for their intended use but rather for purposes like weight loss, which are not covered by the state pharmaceutical subsidy.

A government investigator, Anders Ahlsson, has suggested granting Ivo access to comprehensive data regarding all prescribed medications rather than a limited selection. This change is aimed at improving oversight of the pharmaceutical benefits system, allowing Ivo to conduct more efficient monitoring and intervention against fraudulent prescription practices.

Additionally, the proposal includes empowering Ivo to revoke medical licenses or restrict the right to prescribe medications while investigations are pending. The ability to suspend prescribing rights would extend not just to narcotics but to all types of medications, providing a robust response to the growing issue of prescription abuse in Sweden.